Published in Ann Surg on October 01, 1971
Orthotopic liver transplantation in ninety-three patients. Surg Gynecol Obstet (1976) 8.11
Orthotopic liver transplantation for patients with hepatitis B virus-related liver disease. Hepatology (1991) 3.34
Liver allograft. Its use in chronic active hepatitis with macronodular cirrhosis, hepatitis B surface antigen. Arch Surg (1979) 1.80
Peliosis hepatis in recipients of renal transplants. Gut (1978) 1.48
Cytomegalovirus: Clinical virological correlations in renal transplant recipients. Ann Surg (1974) 1.34
Acute pancreatitis and hyperamylasemia in renal homograft recipients. Arch Surg (1972) 1.24
Serum complement after orthotopic transplantation of the human liver. Clin Exp Immunol (1972) 1.12
Detection of Australia antigen by biological assay in 'Au negative' kidney homograft recipients with hepatic dysfunction. Clin Exp Immunol (1972) 1.06
Hepatitis with Australia antigenemia following renal transplantation. Can Med Assoc J (1973) 0.86
The complement system in renal homograft recipents. Surgery (1972) 0.82
HBs antigenemia in renal allograft recipients. Ann Surg (1977) 0.75
Chronic immunosuppression, Australia antigenemia, and hepatitis. Transplant Proc (1972) 0.75
Jaundice after renal allotransplantation. Ann Surg (1978) 0.75
Application of a microtechnique to viral serological investigations. J Immunol (1962) 51.33
Diffusion-in-gel methods for immunological analysis. Prog Allergy (1958) 27.50
An antigen detected in the blood during the incubation period of serum hepatitis. Proc Natl Acad Sci U S A (1968) 7.33
A serum antigen (Australia antigen) in Down's syndrome, leukemia, and hepatitis. Ann Intern Med (1967) 7.00
FACTORS DETERMINING SHORT- AND LONG-TERM SURVIVAL AFTER ORTHOTOPIC LIVER HOMOTRANSPLANTATION IN THE DOG. Surgery (1965) 6.71
Particles associated with Australia antigen in the sera of patients with leukaemia, Down's Syndrome and hepatitis. Nature (1968) 6.34
A "NEW" ANTIGEN IN LEUKEMIA SERA. JAMA (1965) 6.21
Pathogenesis of chronic disease associated with persistent lymphocytic choriomeningitis viral infection. I. Relationship of antibody production to disease in neonatally infected mice. J Exp Med (1969) 6.03
A BIOCHEMICAL ABNORMALITY IN HEREDIATRY ANGIONEUROTIC EDEMA: ABSENCE OF SERUM INHIBITOR OF C' 1-ESTERASE. Am J Med (1963) 5.19
Immune complexes in hepatitis. Lancet (1969) 4.33
Hepatitis and leukemia: their relation to Australia antigen. Bull N Y Acad Med (1968) 4.28
Human C'3: evidence for the liver as the primary site of synthesis. Science (1969) 4.17
IMMUNOSUPPRESSION AFTER EXPERIMENTAL AND CLINICAL HOMOTRANSPLANTATION OF THE LIVER. Ann Surg (1964) 4.14
Serum hepatitis antigen (SH): rapid detection by high voltage immunoelectroosmophoresis. Science (1970) 4.00
Virus-like antigen, antibody, and antigen-antibody complexes in hepatitis measured by complement fixation. Science (1969) 3.98
Three naturally-occurring inhibitors of components of complement in guinea pig and rabbit serum. J Immunol (1967) 3.86
A unified concept of autoimmune hepatitis. Lancet (1969) 3.74
An epidemic of hepatitis in a chronic-hemodialysis unit. Australia antigen and differences in host response. N Engl J Med (1969) 3.54
Human renal transplantation. I. Clinical experiences with six cases of renal homotransplantation. J Urol (1963) 3.35
Comparative results of cadaver and related donor renal homografts in man, and immunologic implications of the outcome of second and paired transplants. Ann Surg (1966) 3.06
A complement-fixation test for measuring Australia antigen and antibody. J Infect Dis (1969) 2.58
Cellular localisation of Australia antigen in the liver of patients with lymphoproliferative disorders. Lancet (1970) 2.38
Australia antigen and hepatitis. N Engl J Med (1970) 2.35
[Description of a technic simultaneously combining electrophoresis and immunological precipitation in gel: electrosyneresis]. Biochim Biophys Acta (1959) 2.28
Cyclophosphamide therapy in the nephrotic syndrome in childhood. Br Med J (1969) 1.99
Anicteric hepatitis associated with Australia antigen. Occurrence in patients with Down's syndrome. JAMA (1968) 1.94
Transmission of serum hepatitis. JAMA (1970) 1.84
Hepatitis and Australia antigen: autosomal recessive inheritance of susceptibility to infection in humans. Proc Natl Acad Sci U S A (1969) 1.84
Association between lepromatous leprosy and Australia antigen. Lancet (1967) 1.83
INHIBITION OF HEMAGGLUTININ SYNTHESIS BY CYTOXAN. Cancer Res (1965) 1.83
SUPPRESSION OF TISSUE IMMUNITY BY CYCLOPHOSPHAMIDE. Transplantation (1964) 1.72
Australia antigen as a hepatitis virus. Variation in host response. Am J Med (1970) 1.69
Inhibition of complement fixation by human serum. J Immunol (1962) 1.54
Immunofluorescent examination of biopsies from long-term renal allografts. N Engl J Med (1970) 1.53
THE SURVEILLANCE OF TRANSFUSION-ASSOCIATED VIRAL HEPATITIS. JAMA (1965) 1.46
Australia antigen (a hepatitis-associated antigen): purification and physical properties. J Exp Med (1970) 1.46
PROLONGATION OF HOMOGRAFT SURVIVAL IN MICE WITH SINGLE DOSES OF CYCLOPHOSPHAMIDE. Nature (1963) 1.38
Effect of cyclophosphoramide, 6-mercaptopurine, actinomycin D and vincaleukoblastine on the acquisition of delayed hypersensitivity (DNCB) contact dermatitis) in the guinea-pig. J Invest Dermatol (1961) 1.23
Australia antigen and hepatitis. Studies in asymptomatic people and lepromatous leprosy patient. Arch Intern Med (1970) 1.20
Cyclophosphamide in renal homotransplantation. Br J Urol (1966) 1.09
CHANGE IN SERUM HAPTOGLOBIN TYPE FOLLOWING HUMAN LIVER TRANSPLANTATION. Proc Soc Exp Biol Med (1964) 1.08
Electron microscopical and immunological observations on the serum-hepatitis (S.H.) antigen in primary biliary cirrhosis. Lancet (1970) 1.07
Hepatitis-associated (Au-SH) antigen determination in 10,000 patients in a Copenhagen general hospital. Lancet (1970) 1.04
Indications for orthotopic liver transplantation: with particular reference to hepatomas, biliary atresia, cirrhosis, Wilson's disease and serum hepatitis. Transplant Proc (1971) 1.00
Renal transplantation in patients with Australia antigenemia. Transplant Proc (1971) 0.96
Anticomplementary activity of sera from patients with connective tissue disease and normal subjects. J Lab Clin Med (1967) 0.94
Virus-like particles in Australia-antigen-associated hepatitis. Lancet (1970) 0.92
[Human renal homotransplantation. Personal results in 52 patients. 3. Extra-renal complications--general conclusions]. Presse Med (1965) 0.91
Influence of cyclophosphamide on homograft rejection. JAMA (1965) 0.89
Australia antigen serology in the Holy Cross football team hepatitis outbreak. Lancet (1970) 0.86
Effect of cancer chemotherapeutic agents on the survival of homografts of skin. Surg Forum (1961) 0.86
C'3c deficient human sera with a beta-1c precipitin line. J Immunol (1967) 0.85
Prolongation of skin homografts in rabbits, using cyclophosphamide. J Surg Res (1963) 0.85
Purification of C'3 inactivator from human serum. Nature (1968) 0.82
ANTICOMPLEMENTARY PHENOMENA IN MONOCLONAL HYPERGLOBULINEMIA. J Lab Clin Med (1964) 0.81
Viral hepatitis. Current concepts. Postgrad Med (1967) 0.78
Inhibition of complement-mediated hemolysis by rheumatoid arthritis sera studies in agarose gel. Int Arch Allergy Appl Immunol (1970) 0.78
Quantitation of the hepatitis-associated antigen by electroimmunodiffusion. J Allergy (1971) 0.78
Complement-fixation test for Australia antigen. Lancet (1970) 0.78
Au antigen in at-risk patients. Lancet (1970) 0.78
Evolution of liver transplantation. Hepatology (1982) 19.54
A flexible procedure for multiple cadaveric organ procurement. Surg Gynecol Obstet (1984) 10.33
Orthotopic liver transplantation in ninety-three patients. Surg Gynecol Obstet (1976) 8.11
A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators. N Engl J Med (1994) 7.96
The use of cyclosporin A and prednisone in cadaver kidney transplantation. Surg Gynecol Obstet (1980) 7.40
The use of heterologous antilymphoid agents in canine renal and liver homotransplantation and in human renal homotransplantation. Surg Gynecol Obstet (1967) 7.24
Fifteen years of clinical liver transplantation. Gastroenterology (1979) 7.19
Venous bypass in clinical liver transplantation. Ann Surg (1984) 7.04
Liver transplantation with use of cyclosporin a and prednisone. N Engl J Med (1981) 6.95
Orthotopic homotransplantation of the human liver. Ann Surg (1968) 6.64
Vascular homografts from cadaveric organ donors. Surg Gynecol Obstet (1979) 6.23
Long survival in rats after multivisceral versus isolated small-bowel allotransplantation under FK 506. Surgery (1991) 5.92
Infections after liver transplantation. An analysis of 101 consecutive cases. Medicine (Baltimore) (1988) 5.77
Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet (1984) 5.74
Refinements in the surgical technique of liver transplantation. Semin Liver Dis (1985) 5.70
Progress in and deterrents to orthotopic liver transplantation, with special reference to survival, resistance to hyperacute rejection, and biliary duct reconstruction. Transplant Proc (1974) 5.53
Extended survival in 3 cases of orthotopic homotransplantation of the human liver. Surgery (1968) 5.44
Cyclophosphamide and whole organ transplantation in human beings. Surg Gynecol Obstet (1971) 5.24
Alternative methods of arterialization of the hepatic graft. Surg Gynecol Obstet (1984) 5.16
Immunosuppression of canine, monkey, and baboon allografts by FK 506: with special reference to synergism with other drugs and to tolerance induction. Surgery (1988) 5.03
Liver, kidney, and thoracic organ transplantation under FK 506. Ann Surg (1990) 5.01
Conversion from cyclosporine to FK 506 in liver allograft recipients with cyclosporine-related complications. Transplant Proc (1990) 4.90
Pancreaticoduodenal transplantation in humans. Surg Gynecol Obstet (1984) 4.49
Murine liver allograft transplantation: tolerance and donor cell chimerism. Hepatology (1994) 4.32
A simplified technique for revascularization of homografts of the liver with a variant right hepatic artery from the superior mesenteric artery. Surg Gynecol Obstet (1985) 4.29
Heterotopic heart transplantation in the rat receiving FK-506 alone or with cyclosporine. Transplant Proc (1987) 4.21
Pancreatic islet transplantation after upper abdominal exenteration and liver replacement. Lancet (1990) 4.18
Experience in hepatic resection for metastatic colorectal cancer: analysis of clinical and pathologic risk factors. Surgery (1994) 4.16
Orthotopic liver transplantation with preservation of the inferior vena cava. Ann Surg (1989) 4.12
Malignant lymphomas in transplantation patients. Transplant Proc (1969) 4.12
Role of liver transplantation in cancer therapy. Ann Surg (1985) 4.08
Biliary complications after liver transplantation: with special reference to the biliary cast syndrome and techniques of secondary duct repair. Surgery (1977) 4.08
Shwartzman reaction after human renal homotransplantation. N Engl J Med (1968) 4.05
Extended preservation of human liver grafts with UW solution. JAMA (1989) 3.99
Canine and human liver preservation for 6 to 18 hr by cold infusion. Transplantation (1977) 3.99
Clinical presentation of hepatic artery thrombosis after liver transplantation in the cyclosporine era. Transplantation (1985) 3.91
Treatment of rheumatoid arthritis with methotrexate alone, sulfasalazine and hydroxychloroquine, or a combination of all three medications. N Engl J Med (1996) 3.87
The preparation and testing of horse antidog and antihuman antilymphoid plasma or serum and its protein fractions. Surg Gynecol Obstet (1967) 3.86
Replacement of donor lymphoid tissue in small-bowel transplants. Lancet (1991) 3.85
The origin, hormonal nature, and action of hepatotrophic substances in portal venous blood. Surg Gynecol Obstet (1973) 3.84
Left-right asymmetric expression of the TGF beta-family member lefty in mouse embryos. Nature (1996) 3.79
Effects of insulin, glucagon, and insuling/glucagon infusions on liver morphology and cell division after complete portacaval shunt in dogs. Lancet (1976) 3.74
Correlating telomerase activity levels with human neuroblastoma outcomes. Nat Med (1995) 3.74
Immunosuppressive effect of FK-506 on in vitro lymphocyte alloactivation: synergism with cyclosporine A. Transplant Proc (1987) 3.73
Hepatic trisegmentectomy and other liver resections. Surg Gynecol Obstet (1975) 3.66
Right trisegmentectomy for hepatic neoplasms. Surg Gynecol Obstet (1980) 3.64
Variable chimerism, graft-versus-host disease, and tolerance after different kinds of cell and whole organ transplantation from Lewis to brown Norway rats. Transplantation (1995) 3.63
Hepatic Retransplantation. Transplant Proc (1985) 3.62
Hepatic resection versus transplantation for hepatocellular carcinoma. Ann Surg (1991) 3.57
Canine liver transplantation under Nva2-cyclosporine versus cyclosporine. Transplantation (1986) 3.54
Highly purified murine interleukin 5 (IL-5) stimulates eosinophil function and prolongs in vitro survival. IL-5 as an eosinophil chemotactic factor. J Exp Med (1988) 3.50
Combination donor hepatectomy and nephrectomy and early functional results of allografts. Surg Gynecol Obstet (1982) 3.49
Golimumab, a human antibody to tumour necrosis factor {alpha} given by monthly subcutaneous injections, in active rheumatoid arthritis despite methotrexate therapy: the GO-FORWARD Study. Ann Rheum Dis (2008) 3.42
Nephrotoxicity of cyclosporin A in liver and kidney transplant patients. Lancet (1981) 3.38
The relation of preoperative coagulation findings to diagnosis, blood usage, and survival in adult liver transplantation. Transplantation (1985) 3.38
Orthotopic liver transplantation for patients with hepatitis B virus-related liver disease. Hepatology (1991) 3.34
Kidney transplantation under FK 506 immunosuppression. Transplant Proc (1991) 3.31
Early trials with FK 506 as primary treatment in liver transplantation. Transplant Proc (1990) 3.29
Use of OKT3 with cyclosporin and steroids for reversal of acute kidney and liver allograft rejection. Nephron (1987) 3.26
Delayed biliary duct obstruction after orthotopic liver transplantation. Surgery (1972) 3.26
The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression. Am J Pathol (1988) 3.24
Changes in blood coagulation. Arch Surg (1966) 3.22
Rejection of multivisceral allografts in rats: a sequential analysis with comparison to isolated orthotopic small-bowel and liver grafts. Surgery (1990) 3.18
Renal transplantation in baboons under FK 506. Surgery (1989) 3.17
Intraoperative changes in blood coagulation and thrombelastographic monitoring in liver transplantation. Anesth Analg (1985) 3.17
Pathology of hepatic transplantation: A review of 62 adult allograft recipients immunosuppressed with a cyclosporine/steroid regimen. Am J Pathol (1985) 3.16
Liver transplantation before 1 year of age. J Pediatr (1987) 3.15
In Vitro Immunosuppressive Effects of FK506 in Combination With Other Drugs. Transplant Proc (1988) 3.15
The effect of graft function on FK506 plasma levels, dosages, and renal function, with particular reference to the liver. Transplantation (1991) 3.14
High-dose intravenous gammaglobulin for Kawasaki disease. Lancet (1984) 3.10
Fungal infections in liver transplant recipients. Transplantation (1985) 3.07